PackTalk is a blog for the Healthcare Packaging Industry

Eli Lilly Starts Human Study of Potential COVID-19 Antibody Test


Published on June 4, 2020

Companies and research institutions around the world are racing to find a viable treatment for COVID-19, which has already caused ~370,000 deaths worldwide and continues to rise. Eli Lilly recently announced their progress, and are moving into the human study portion of their antibody treatment. They have developed this treatment from a blood sample that was taken from one of the first patients in the United States to have recovered from the lung illness caused by COVID-19. 

Eli Lilly is anticipating results to their study by end of June. Read more about the treatment here.


Comments (0)

Related Articles

New Nylon Opens Door for Companies Looking to Upgrade Packaging at a More Afford...

July 3, 2020

To our readers … you know by now that we never push our product through PackTalk. In this blog, we aim to educate & inspire, and ultimately start a discussion. But we’re breaking our own rule for this article.  The healthcare industry is conservative...

Learn More

Analysts Report Positive Signs for Elective Procedure Volume Recovery

July 3, 2020

During the peak of COVID-19, a majority of non-emergency or elective medical procedures were put on hold. The lack of procedures had a significant impact on the medical device industry and it’s still questionable when we’ll see procedure volume return to...

Learn More

Healthcare Agility in the Time of COVID-19

July 3, 2020

The healthcare world has faced a massive shift in recent months to focus on fighting the COVID-19 pandemic. The medical system has suffered unprecedented strain, and there has been global coordination in ways we have never before seen. Hospitals have...

Learn More

Stay Informed

To stay up to date on innovative technology and products, as well as industry trends, subscribe to Oliver’s PackTalk blog below.